Common Contracts

2 similar Investors’ Rights Agreement contracts by Odyssey Therapeutics, Inc.

THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT
Investors’ Rights Agreement • April 17th, 2026 • Odyssey Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware

THIS THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of June 16, 2025, by and among ODYSSEY THERAPEUTICS, INC., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”.

THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT
Investors’ Rights Agreement • March 16th, 2026 • Odyssey Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware

THIS THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of June 16, 2025, by and among ODYSSEY THERAPEUTICS, INC., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”.